secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0000950170-23-048392
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics receives Nasdaq bid price deficiency notice; delisting risk
-------------------------------------------------------------------------------

- Received Nasdaq letter on Sept 13, 2023; bid price below $1.00 for 30 consecutive days.
- Must regain compliance by March 11, 2024; bid price must close at $1.00+ for 10 consecutive days.
- If not compliant, may seek 180-day extension by meeting other listing standards and effecting reverse stock split.
- Failure to regain compliance may result in delisting; company evaluating options to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017023048392/0000950170-23-048392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017023048392/apvo-20230913.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-048392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer